Adtraction Group AB
F:Q59
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Adtraction Group AB
F:Q59
|
SE |
|
S
|
Sandoz Group AG
SIX:SDZ
|
CH |
|
X
|
Xerox Holdings Corp
XETRA:XER2
|
US |
|
Gurit Holding AG
SIX:GURN
|
CH |
|
Futura Medical PLC
LSE:FUM
|
UK |
|
N
|
NovaBay Pharmaceuticals Inc
XBER:B9P
|
US |
|
A
|
Arion Entertainment Singapore Ltd
SGX:YYB
|
SG |
|
B
|
Brook Crompton Holdings Ltd
SGX:AWC
|
SG |
|
M
|
Man Industries India Ltd
NSE:MANINDS
|
IN |
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
W
|
Wee Hur Holdings Ltd
SGX:E3B
|
SG |
|
N
|
Nike Inc
XETRA:NKE
|
US |
|
F
|
Ferrum SA
WSE:FER
|
PL |
|
Garb Oil & Power Corp
OTC:GARB
|
US |
|
Harris Technology Group Ltd
ASX:HT8
|
AU |
|
Yunnan Metropolitan Real Estate Development Co Ltd
SSE:600239
|
CN |
|
Sultan Resources Ltd
ASX:SLZ
|
AU |
|
MPC Muenchmeyer Petersen Capital AG
XETRA:MPCK
|
DE |
|
Entegris Inc
NASDAQ:ENTG
|
US |
|
Dongwon Industries Co Ltd
KRX:006040
|
KR |
|
Iervolino & Lady Bacardi Entertainment SpA
MIL:IE
|
IT |
|
A
|
ACS Actividades de Construccion y Servicios SA
VSE:ACS
|
ES |
|
D
|
Dar Global PLC
LSE:DAR
|
UK |
|
Maxigen Biotech Inc
TWSE:1783
|
TW |
Balance Sheet
Balance Sheet Decomposition
Adtraction Group AB
Adtraction Group AB
Balance Sheet
Adtraction Group AB
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
30
|
31
|
52
|
141
|
142
|
116
|
107
|
124
|
|
| Cash Equivalents |
30
|
31
|
52
|
141
|
142
|
116
|
107
|
124
|
|
| Total Receivables |
87
|
103
|
110
|
53
|
85
|
138
|
107
|
112
|
|
| Accounts Receivables |
79
|
99
|
107
|
47
|
75
|
125
|
102
|
105
|
|
| Other Receivables |
8
|
4
|
3
|
6
|
10
|
13
|
6
|
6
|
|
| Other Current Assets |
1
|
2
|
2
|
90
|
98
|
104
|
137
|
133
|
|
| Total Current Assets |
118
|
136
|
165
|
284
|
325
|
358
|
352
|
368
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
36
|
30
|
136
|
109
|
75
|
|
| Goodwill |
0
|
0
|
20
|
30
|
25
|
123
|
104
|
68
|
|
| Note Receivable |
0
|
0
|
0
|
1
|
1
|
2
|
23
|
21
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
|
| Other Assets |
0
|
0
|
20
|
30
|
25
|
123
|
104
|
68
|
|
| Total Assets |
118
N/A
|
137
+16%
|
186
+36%
|
351
+89%
|
381
+9%
|
619
+62%
|
591
-5%
|
536
-9%
|
|
| Liabilities | |||||||||
| Accounts Payable |
33
|
35
|
1
|
13
|
4
|
6
|
3
|
6
|
|
| Accrued Liabilities |
44
|
57
|
118
|
146
|
184
|
234
|
252
|
262
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
3
|
10
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
13
|
15
|
12
|
23
|
30
|
35
|
35
|
41
|
|
| Total Current Liabilities |
90
|
107
|
135
|
191
|
218
|
275
|
289
|
309
|
|
| Long-Term Debt |
0
|
0
|
6
|
15
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
9
|
7
|
29
|
23
|
16
|
|
| Minority Interest |
1
|
1
|
8
|
7
|
5
|
4
|
2
|
1
|
|
| Other Liabilities |
0
|
0
|
4
|
4
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
91
N/A
|
109
+19%
|
154
+41%
|
226
+47%
|
230
+2%
|
308
+34%
|
315
+2%
|
326
+4%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
27
|
28
|
33
|
23
|
43
|
42
|
1
|
57
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
100
|
100
|
265
|
265
|
265
|
|
| Other Equity |
0
|
0
|
1
|
1
|
7
|
3
|
12
|
2
|
|
| Total Equity |
27
N/A
|
28
+5%
|
32
+14%
|
125
+289%
|
151
+21%
|
311
+106%
|
276
-11%
|
210
-24%
|
|
| Total Liabilities & Equity |
118
N/A
|
137
+16%
|
186
+36%
|
351
+89%
|
381
+9%
|
619
+62%
|
591
-5%
|
536
-9%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
11
|
11
|
11
|
11
|
11
|
15
|
15
|
15
|
|